ALT
Price
$7.03
Change
+$0.24 (+3.53%)
Updated
Nov 5 closing price
6 days until earnings call
RCKT
Price
$17.19
Change
+$0.37 (+2.20%)
Updated
Nov 5 closing price
Earnings call today
Ad is loading...

ALT vs RCKT

Header iconALT vs RCKT Comparison
Open Charts ALT vs RCKTBanner chart's image
Altimmune
Price$7.03
Change+$0.24 (+3.53%)
Volume$1.68M
CapitalizationN/A
Rocket Pharmaceuticals
Price$17.19
Change+$0.37 (+2.20%)
Volume$980.97K
CapitalizationN/A
View a ticker or compare two or three
ALT vs RCKT Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALT vs. RCKT commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Buy and RCKT is a Hold.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (ALT: $7.03 vs. RCKT: $17.19)
Brand notoriety: ALT and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 82% vs. RCKT: 110%
Market capitalization -- ALT: $499.63M vs. RCKT: $1.56B
ALT [@Biotechnology] is valued at $499.63M. RCKT’s [@Biotechnology] market capitalization is $1.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, RCKT is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 7 TA indicator(s) are bullish while RCKT’s TA Score has 3 bullish TA indicator(s).

  • ALT’s TA Score: 7 bullish, 2 bearish.
  • RCKT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ALT is a better buy in the short-term than RCKT.

Price Growth

ALT (@Biotechnology) experienced а -4.48% price change this week, while RCKT (@Biotechnology) price change was -0.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.94%. For the same industry, the average monthly price growth was +11.15%, and the average quarterly price growth was +8.66%.

Reported Earning Dates

ALT is expected to report earnings on Mar 27, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-0.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($1.56B) has a higher market cap than ALT($500M). ALT YTD gains are higher at: -37.511 vs. RCKT (-42.643). ALT has higher annual earnings (EBITDA): -100.91M vs. RCKT (-243.06M). RCKT has more cash in the bank: 279M vs. ALT (165M). ALT has less debt than RCKT: ALT (1.86M) vs RCKT (25.8M). ALT has higher revenues than RCKT: ALT (409K) vs RCKT (0).
ALTRCKTALT / RCKT
Capitalization500M1.56B32%
EBITDA-100.91M-243.06M42%
Gain YTD-37.511-42.64388%
P/E RatioN/AN/A-
Revenue409K0-
Total Cash165M279M59%
Total Debt1.86M25.8M7%
FUNDAMENTALS RATINGS
ALT vs RCKT: Fundamental Ratings
ALT
RCKT
OUTLOOK RATING
1..100
1364
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
8087
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3863
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (45) in the Biotechnology industry is somewhat better than the same rating for ALT (84) in the Miscellaneous Commercial Services industry. This means that RCKT’s stock grew somewhat faster than ALT’s over the last 12 months.

ALT's Profit vs Risk Rating (80) in the Miscellaneous Commercial Services industry is in the same range as RCKT (87) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

ALT's SMR Rating (97) in the Miscellaneous Commercial Services industry is in the same range as RCKT (97) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

ALT's Price Growth Rating (38) in the Miscellaneous Commercial Services industry is in the same range as RCKT (63) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

ALT's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as RCKT (100) in the Biotechnology industry. This means that ALT’s stock grew similarly to RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTRCKT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 20 days ago
84%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMCAX65.280.94
+1.46%
Empiric Class A
AWSSX17.240.18
+1.06%
Invesco Global Core Equity R6
NILTX14.080.14
+1.00%
Neuberger Berman International Sel Tr
GSCKX14.80N/A
N/A
Goldman Sachs International Eq Inc C
TESRX27.01N/A
N/A
Franklin Mutual Shares R

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with DNLI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+2.20%
DNLI - RCKT
56%
Loosely correlated
+1.62%
NTLA - RCKT
55%
Loosely correlated
+1.92%
RYTM - RCKT
53%
Loosely correlated
+6.15%
AXON - RCKT
52%
Loosely correlated
+2.21%
ALEC - RCKT
52%
Loosely correlated
-5.22%
More